These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

223 related articles for article (PubMed ID: 5307100)

  • 21. Plutonium-contaminated wound studies in swine. BNWL-480.
    McClanahan BJ; Ragan HA
    BNWL Rep; 1966 Jan; ():101-3. PubMed ID: 5300992
    [No Abstract]   [Full Text] [Related]  

  • 22. Plutonium ( 239 Pu) toxicity diagnosis and therapy.
    Norwood WD
    J Occup Med; 1972 Jan; 14(1):37-44. PubMed ID: 5058618
    [No Abstract]   [Full Text] [Related]  

  • 23. Experimental background for prompt treatment with DTPA of 239Pu-contaminated wounds.
    Volf V
    Health Phys; 1974 Sep; 27(3):273-7. PubMed ID: 4436049
    [No Abstract]   [Full Text] [Related]  

  • 24. Investigations into techniques for removing intracellular plutonium--II. Complexing agents bound to macromolecules.
    Bulman RA; Griffin RJ
    Health Phys; 1981 Feb; 40(2):228-31. PubMed ID: 6163749
    [No Abstract]   [Full Text] [Related]  

  • 25. [Assessment of the body uptake and the effectiveness of the deactivation of abrasions and wounds contaminated by 238Pu].
    Bazhin AG
    Gig Sanit; 1985 Dec; (12):74-6. PubMed ID: 4092962
    [No Abstract]   [Full Text] [Related]  

  • 26. Simplified structure of a new model to describe urinary excretion of plutonium after systemic, liver or pulmonary contamination of rats associated with Ca-DTPA treatments.
    Fritsch P; Sérandour AL; Grémy O; Phan G; Tsapis N; Abram MC; Renault D; Fattal E; Benech H; Deverre JR; Poncy JL
    Radiat Res; 2009 Jun; 171(6):674-86. PubMed ID: 19580474
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Chelating agents used for plutonium and uranium removal in radiation emergency medicine.
    Fukuda S
    Curr Med Chem; 2005; 12(23):2765-70. PubMed ID: 16305471
    [TBL] [Abstract][Full Text] [Related]  

  • 28. EFFECTS OF PLUTONIUM IN SKIN AND IN REMOVAL. HW-76000.
    CABLE JW; MCCLANAHAN BJ; HORSTMAN VG; WOOD DH; BUSTAD LK
    HW SA US At Energy Comm; 1963 Jan; 86():149-55. PubMed ID: 24547060
    [No Abstract]   [Full Text] [Related]  

  • 29. [Late sequelae of the inhalational uptake of 239Pu under the influence of Ca- or ZnDTPA therapy].
    Levdik TI; Liubchanskii ER; Nifatov AP
    Med Radiol (Mosk); 1979 Nov; 24(11):66-71. PubMed ID: 502784
    [No Abstract]   [Full Text] [Related]  

  • 30. Derivation and validation of a urinary excretion function for plutonium based on occupational exposure.
    Yadav JR; Rao DD; Hegde AG; Aggarwal SK
    Radiat Prot Dosimetry; 2008; 129(4):386-90. PubMed ID: 17974581
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effect of age and physicochemical form on plutonium toxicity and metabolism in the rat. BNWL-714.
    Sikov MR; Mahlum DD
    BNWL Rep; 1968 May; ():5.8-5+. PubMed ID: 5307096
    [No Abstract]   [Full Text] [Related]  

  • 32. [Report on a plutonium-239 contaminated lacerated and incised wound].
    Ohlenschläger L; Schieferdecker H
    Strahlentherapie; 1973 Dec; 146(6):675-84. PubMed ID: 4792264
    [No Abstract]   [Full Text] [Related]  

  • 33. Combined drug and surgery treatment of plutonium-contaminated wounds: indications obtained using a rodent model.
    Griffiths NM; Coudert S; Wilk JC; Renault D; Angulo JF; Van der Meeren A
    Health Phys; 2014 Jun; 106(6):638-44. PubMed ID: 24776894
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Emergency care for acute wound entering of plutonium and americium into the body (real case)].
    Krasniuk VI; Gasteva GN; Blinov AP; Kuz'menko LG
    Med Tr Prom Ekol; 2005; (3):45-8. PubMed ID: 15859507
    [TBL] [Abstract][Full Text] [Related]  

  • 35. PREVENTION OF PLUTONIUM AND NEPTUNIUM DEPOSITION. HW-76000.
    SMITH VH
    HW SA US At Energy Comm; 1963 Jan; 86():143-8. PubMed ID: 24547059
    [No Abstract]   [Full Text] [Related]  

  • 36. Effects of frequency of administration of DTPA on the excretion and tissue retention of 144Ce from a contaminated wound in the rat.
    Takada K; Fujita M
    Health Phys; 1979 Sep; 37(3):401-5. PubMed ID: 511571
    [No Abstract]   [Full Text] [Related]  

  • 37. Specific sequestering agents for the actinides. 4. Removal of 238Pu(IV) from mice by sulfonated tetrameric catechoyl amides.
    Durbin PW; Jones ES; Raymond KN; Weitl FL
    Radiat Res; 1980 Feb; 81(2):170-87. PubMed ID: 6444746
    [No Abstract]   [Full Text] [Related]  

  • 38. [Tumors in rats that have received pentacin after the administration of plutonium-239].
    Bukhtoiarova EM; Lemberg VK; Erokhin RA; Beliaev IuA
    Vopr Onkol; 1968; 14(8):71-6. PubMed ID: 5247174
    [No Abstract]   [Full Text] [Related]  

  • 39. Phagocytosis and translocation of intraperitoneally injected 239PuO2 and 238PuO2 particles. BNWL-714.
    Sanders CL
    BNWL Rep; 1968 May; ():6.13-6+. PubMed ID: 5307097
    [No Abstract]   [Full Text] [Related]  

  • 40. Importance of initial management of persons internally contaminated with radionuclides.
    Lincoln TA
    Am Ind Hyg Assoc J; 1976 Jan; 37(1):16-21. PubMed ID: 1246944
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.